These findings suggest that OSCC expression of COX-1 could be contributing to PGE2 level and tumor-associated inflammation, despite most of the attention being paid to COX-2 expression (and COX-2 inhibitors) in the OSCC-related literature. This evidence concerns the gene PTGS2 and neoplasm.